Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Trinity Biotech plc TRIB
$0.97
-$0.03 (-2.76%)
На 18:01, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
37836986.00000000
-
week52high
1.50
-
week52low
0.80
-
Revenue
74779000
-
P/E TTM
-1
-
Beta
1.40449800
-
EPS
-1.27000000
-
Last Dividend
1.19000000
-
Next Earnings Date
23 мар 2023 г. в 14:00
Описание компании
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Stephens & Co. | Equal-weight | Overweight | 05 окт 2016 г. |
| Stephens & Co. | Overweight | 29 мая 2015 г. | |
| Roth Capital | Buy | Neutral | 30 апр 2014 г. |
| Craig-Hallum | Buy | 05 мар 2013 г. | |
| Roth Capital | Neutral | Buy | 22 янв 2013 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2022 Financial Results
GlobeNewsWire
16 мар 2023 г. в 15:30
Conference Call Scheduled for March 23, 2023 at 10:00 am EASTERN Conference Call Scheduled for March 23, 2023 at 10:00 am EASTERN
Trinity Biotech plc (TRIB) Q3 2022 Earnings Call Transcript
Seeking Alpha
15 дек 2022 г. в 14:11
Trinity Biotech plc (NASDAQ:TRIB ) Q3 2022 Earnings Conference Call December 15, 2022 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Aris Kekedjian - Chief Executive Officer John Gillard - Chief Financial Officer Conference Call Participants Jim Sidoti - Sidoti & Company Paul Nouri - Noble Equity Fund Operator Good day. And welcome to the Trinity Biotech Third Quarter Financial Results Conference Call.
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results
GlobeNewsWire
09 дек 2022 г. в 05:35
Conference Call Scheduled for December 15, 2022 at 11:00 am EASTERN Conference Call Scheduled for December 15, 2022 at 11:00 am EASTERN
Trinity Biotech plc (TRIB) Q2 2022 Earnings Call Transcript
Seeking Alpha
05 ноя 2022 г. в 12:52
Trinity Biotech plc (NASDAQ:TRIB ) Q2 2022 Results Conference Call November 3, 2022 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Aris Kekedjian - Chief Executive Officer John Gillard - Chief Financial Officer and Director Conference Call Participants Jim Sidoti - Sidoti & Company Paul Nouri - Noble Equity Operator Good day, and welcome to the Trinity Biotech Second Quarter Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2022 Financial Results
GlobeNewsWire
01 ноя 2022 г. в 09:15
Conference Call Scheduled for November 3, 2022 at 11:00 am EASTERN Conference Call Scheduled for November 3, 2022 at 11:00 am EASTERN